These were the first identified cases of CA5A deficiency in the Bedouin population, emphasizing the importance of a high index of suspicion, early genetic consultation and diagnosis, and prompt treatment at the earliest possible stage of a hyperammonemic crisis. The gene discussed is CA5A; the disease is hyperinsulinemic hypoglycemia, familial, 4.